Skip to content
Cure51 logo

Cure51 Alternatives & Competitors

12 companies similar to Cure51 — We want every patient to become a Cancer Survivor.

Companies similar to Cure51

Alterome Therapeutics, Inc logo — alternative to Cure51
Cybrexa Therapeutics logo — alternative to Cure51

Cybrexa Therapeutics

Changing the paradigm for cancer treatment through the development of antigen-independent...

BlossomHill Therapeutics, Inc. logo — alternative to Cure51

BlossomHill Therapeutics, Inc.

Addressing urgent unmet medical needs through deeper science, true originality, and rich e...

Prokarium logo — alternative to Cure51

Prokarium

LIVING CURES

Rival Readout

Competing with Cure51? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout
DEM Biopharma, Inc. logo — alternative to Cure51

DEM Biopharma, Inc.

Novel Target for Solid Tumors

RayzeBio logo — alternative to Cure51

RayzeBio

Targeted innovative radiopharmaceuticals for cancer

Prelude Therapeutics logo — alternative to Cure51

Prelude Therapeutics

Precision Oncology, Redefined.

Onchilles Pharma logo — alternative to Cure51

Onchilles Pharma

Developing drug candidates that have the potential to be broadly effective against a wide...

OnCusp Therapeutics logo — alternative to Cure51

OnCusp Therapeutics

We Bring Oncology Innovation to Life

Chordia Therapeutics Inc logo — alternative to Cure51

Chordia Therapeutics Inc

We are passionate to deliver first in class cancer drugs to patients from Japan.

Promatix Biosciences Ltd logo — alternative to Cure51

Promatix Biosciences Ltd

Using multi-omics to develop the next generation of cancer therapeutics

INOVOTION logo — alternative to Cure51

INOVOTION

Which molecule will stand out

About Cure51

Cure51, founded in 2021, is a TechBio startup revolutionizing cancer research through its pioneering global database of Cancer Survivors with the mission: “We want every patient to become a Cancer Survivor.” Founded in collaboration with leading oncology centers, Cure51 has identified over 1,500 survivors across 42 cou...

Services

Creating precision oncology drugs, Establishing and maintaining global cancer networks, Data collection and analysis from cancer outlier patients, Developing multi-omics database and clinical libraries

Target Customers

Oncology Centers, Cancer Researchers, Pharmaceutical Companies, Healthcare Providers, Cancer Patients

Business keywords

TechBio, Cancer Survivor Database, Oncology Partnerships, Data Collection Platform, Multiomic Sequencing, Therapeutic Target Identification, Novel Drug Development, Aggressive Cancer Focus, Global Cancer Research, Scientific Community Validation, Central Lab Infrastructure, Cancer Research Collaboration, Bioinformatics, Personalized Medicine

Business Model

B2B, Platform, DaaS

Revenue Model

Licensing, Data Monetization, Project Based

Frequently Asked Questions

Companies similar to Cure51 include Alterome Therapeutics, Inc, Cybrexa Therapeutics, BlossomHill Therapeutics, Inc., Prokarium, DEM Biopharma, Inc.. They work in Biotechnology and Pharmaceutical.
Bounce Watch lists 12 companies that share Cure51's industries and are closest to it in business tags, services, target customers, business model and size.
Cure51, founded in 2021, is a TechBio startup revolutionizing cancer research through its pioneering global database of Cancer Survivors with the mission: “We want every patient to become a Cancer Survivor.” Founded in collaboration with leading oncology centers, Cure51 has identified over 1,500 survivors across 42 cou...

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around Cure51: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Compiled from the BounceWatch company index. We last looked at Cure51 on 25 Aug 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout